Pharmaceutical developers at Synthon, a global specialist in the development and manufacture of generic medicines, have chosen an Optim 1000 high throughput, micro-volume protein analysis system from Avacta for preliminary formulation studies.
Avacta Analytical, a leading provider of analytical services and technologies, has unveiled the Optim® 2 microvolume protein analysis and characterisation instrument.
Avacta Group - a UK-based healthcare technology and consumables business - has expanded its Yorkshire headquarters with the addition of new laboratory, office and manufacturing space.
Avacta Analytical is partnering with University College London (UCL) as an industrial sponsor of the EPSRC Centre for Innovative Manufacturing in Emergent Macromolecular Therapies, which also involves Imperial College London and the London School of Pharmacy.
Satisfied Users & 
Approved Press Releases
